Abstract
The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 718-720 |
| Number of pages | 3 |
| Journal | Infection Control and Hospital Epidemiology |
| Volume | 38 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved.
Fingerprint
Dive into the research topics of 'Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS